TRANSPHORM INC (TGAN) Stock Analyst Ratings
USA - NASDAQ:TGAN - US89386L1008 - Common Stock
5.1 USD
+0.34 (+7.14%)
5.0998 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 78% to TGAN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.66. This target is 11% above the current price.
TGAN was analyzed by 9 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about TGAN.
In the previous month the buy percentage consensus was at a similar level.
TGAN was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-01-16 | Benchmark | Downgrade | Buy -> Hold |
| 2023-10-13 | Benchmark | Maintains | Buy -> Buy |
| 2023-08-15 | Benchmark | Reiterate | Buy -> Buy |
| 2023-08-15 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2023-06-28 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2022-08-16 | Benchmark | Maintains | Buy |
| 2022-06-15 | B. Riley Securities | Downgrade | Buy -> Neutral |
| 2022-05-25 | B. Riley Securities | Maintains | Buy |
TRANSPHORM INC / TGAN FAQ
What do analysts expect the price target to be for TRANSPHORM INC (TGAN)?
9 analysts have analysed TGAN and the average price target is 5.66 USD. This implies a price increase of 11% is expected in the next year compared to the current price of 5.1.
How do analysts rate TRANSPHORM INC (TGAN)?
The consensus rating for TRANSPHORM INC (TGAN) is 77.7778 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover TRANSPHORM INC (TGAN) stock?
The number of analysts covering TRANSPHORM INC (TGAN) is 9.